Analysts now put their average fair value estimate for NHN at about ₩36,880 per share, up from roughly ₩33,533. This reflects updated assumptions around revenue growth, profit margins, the discount rate and a higher expected future P/E multiple.
What's in the News
- NHN completed a share repurchase program, buying 420,562 shares, equal to 1.35% of its shares, for a total of ₩12,831.39 million between October 23, 2025 and December 8, 2025 (Key Developments).
Valuation Changes
- Fair Value, the updated average fair value estimate is ₩36,880 per share, compared with the previous figure of about ₩33,533.
- Discount Rate, adjusted slightly to 9.55% from 9.75%, reflecting a modest change in the rate used to discount future cash flows.
- Revenue Growth, the revised assumption is 8.44% from 7.95%, indicating a slightly higher projected top line growth rate in the model.
- Net Profit Margin, reset to 3.85% from 5.20%, reflecting a more conservative view on future profitability relative to revenue.
- Future P/E, the updated valuation multiple is 11.56x from 7.95x, which raises the long-term earnings multiple applied in the analysis.
Have other thoughts on NHN?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.